This morning I saw my surgeon for the first time since the end of March. He wins the prize for my favourite specialist thus far. He’s a listener, empathetic and easy to chat with.
All’s looking good on the wound front. While I had him as a captive audience, I asked questions about the aromatase inhibitor regime I may start in August. I’m particularly concerned about the bone density impacts of these drugs. He accessed my last bone density scan and confirmed that given already established loss, in his view, I would need to consider bone strengthening drugs to counteract the effects of the AI drug.
Sigh. There are so many unanswered questions. We’re talking about drugs to address what other drugs damage. Drugs that also have their own negative impacts. Drugs that may/are likely to/will affect quality of life factors for years.
There is much to mull over.
excerpt from Cancer Australia’s Guide for Women with Early Breast Cancer